|
1
|
Hanania AN, Mainwaring W, Ghebre YT,
Hanania NA and Ludwig M: Radiation-induced lung injury: Assessment
and management. Chest. 156:150–162. 2019.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Wang Y, Zhang J and Shao C: Cytological
changes in radiation-induced lung injury. Life Sci.
358(123188)2024.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Ruysscher D, Wauters E, Jendrossek V,
Filippi AR, Revel MP, Faivre-Finn C, Naidoo J, Ramella S,
Guckenberger M, Ricardi U, et al: Diagnosis and treatment of
radiation induced pneumonitis in patients with lung cancer: An
ESTRO clinical practice guideline. Radiother Oncol.
207(110837)2025.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Jackson IL and Doyle-Eisele M: Animal
model considerations for medical countermeasure development for
radiation and sulfur mustard exposures: Animal models for radiation
and HD exposures. Disaster Med Public Health Prep.
18(e81)2023.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Zhang X, Zhang Z, Huang M, Jin Y, Huang Y,
Ji P and Ma Z: Pathological mechanisms of radiation-induced lung
injury and novel nano-drug delivery therapeutic strategies. Int J
Nanomedicine. 20:12431–12465. 2025.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Thamer ZA, Muhammed RS and Sharrad AA:
Effects of radiation ionizer on vital molecules: Chemical
mechanisms and omics (Ombus) techniques for detection and analysis.
J Med Phys. 50:781–789. 2025.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Chen YY, Wang M, Zuo CY, Mao MX, Peng XC
and Cai J: Nrf-2 as a novel target in radiation induced lung
injury. Heliyon. 10(e29492)2024.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Piraino LR, Chen CY, Mereness JA, Dunman
PM, Ovitt CE, Benoit DSW and DeLouise LA: Salivary gland tissue
chip screening identifies candidate radioprotective drugs. Commun
Med (Lond). 5(420)2025.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Antonadou D, Coliarakis N, Synodinou M,
Athanassiou H, Kouveli A, Verigos C, Georgakopoulos G, Panoussaki
K, Karageorgis P and Throuvalas N: Clinical Radiation Oncololgy
Hellenic Group. Randomized phase III trial of radiation treatment
+/- amifostine in patients with advanced-stage lung cancer. Int J
Radiat Oncol Biol Phys. 51:915–922. 2001.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Komaki R, Chang JY, Wu X, Allen PK, Milas
L, Liao Z, Fossella FV, Travis E and Spitz MR: Mutagen sensitivity
may predict lung protection by amifostine for patients with locally
advanced non-small cell lung cancer treated by chemoradiotherapy.
Semin Oncol. 32 (Suppl 3):S92–S98. 2005.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Mehta V: Open label multicenter trial of
subcutaneous amifostine (Ethyol) in the prevention of radiation
induced esophagitis and pneumonitis in patients with measurable,
unresectable non-small cell lung cancer. Semin Oncol. 31 (Suppl
18):S42–S46. 2004.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Chen T, Zhuang B, Huang Y, Wang W and Jin
Y: Inhaled amifostine for the prevention of radiation-induced lung
injury. Radiat Med Prot. 3:72–80. 2022.
|
|
13
|
Maghsadi Z, Azadmehr A, Moghadamnia AA,
Feizi F and Hamidi N: N-Acetylcysteine attenuated pulmonary
fibrosis induced by bleomycin via immunomodulation responses. Res
Pharm Sci. 18:177–184. 2023.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Han DW, Ji W, Lee JC, Song SY and Choi CM:
Efficacy of nebulized acetylcysteine for relieving symptoms and
reducing usage of expectorants in patients with radiation
pneumonitis. Thorac Cancer. 10:243–248. 2019.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Talebpour Amiri F, Asghari M and
Hosseinimehr SJ: Omeprazole attenuates irradiation-induced lung
injury through the suppression of apoptosis and oxidative stress in
mice. Med Oncol. 42(172)2025.PubMed/NCBI View Article : Google Scholar
|
|
16
|
English J, Dhanikonda S, Tanaka KE, Koba
W, Eichenbaum G, Yang WL and Guha C: Thrombopoietin mimetic reduces
mouse lung inflammation and fibrosis after radiation by attenuating
activated endothelial phenotypes. JCI insight.
9(e181330)2024.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Baralić K, Živanović J, Božović P,
Kržanović N, Šćepanović N, Petrović J and Đukić-Ćosić D: Protective
effects of curcumin and sulforaphane against ionising
radiation-induced oxidative stress and inflammatory responses in
rat lung tissue. Antioxidants (Basel). 15(255)2026.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Seyedpour N, Motevaseli E, Taeb S,
Nowrouzi A, Mirzaei F, Bahri M, Dehghan-Manshadi HR, Zhaleh M,
Rashidi K, Azmoonfar R, et al: Protective effects of alpha-lipoic
acid, resveratrol, and apigenin against oxidative damages,
histopathological changes, and mortality induced by lung
irradiation in rats. Curr Radiopharm. 17:99–110. 2024.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Ning X, Zhao W, Wu Q, Wang C and Liang S:
Therapeutic potential of dihydroartemisinin in mitigating
radiation-induced lung injury: Inhibition of ferroptosis through
Nrf2/HO-1 pathways in mice. Immun Inflamm Dis.
12(e1175)2024.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Park SH, Kim JY, Kim JM, Yoo BR, Han SY,
Jung YJ, Bae H and Cho J: PM014 attenuates radiation-induced
pulmonary fibrosis via regulating NF-kB and TGF-b1/NOX4 pathways.
Sci Rep. 10(16112)2020.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Zhang N, Yang X, Liang J, Zhu C, Shen G,
Luo C and Wu W: Tanshinone IIA inhibits alveolar macrophage
polarization, inflammation and mitochondrial damage by regulating
the PAPR-1 signaling pathway. Iran J Pharm Res.
24(e166272)2025.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Zhang D, He J, Cui J, Wang R and Zhou M:
Inhalable nano-astaxanthin for radiation-induced lung injury via
enhanced lung retention and inflammation suppression. ACS Appl
Mater Interfaces. 17:64295–64308. 2025.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Mirzaei F, Khosravi H, Najafi M, Salimi M,
Varkeshi M, Pashaki AS and Azmoonfar R: Histopathological
evaluation of radioprotective effects: Selenium nanoparticles
protect lung tissue from radiation damage. Adv Biomed Res.
14(77)2025.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Guo H, Yu R, Zhang H and Wang W: Cytokine,
chemokine alterations and immune cell infiltration in
radiation-induced lung injury: Implications for prevention and
management. Int Immunopharmacol. 126(111263)2024.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Li E, Huang J, Huang J, Zhang F, Li C, Xia
M, Li Z, Peng B, Liu Y, Ma J and Lei M: ALDH2 attenuates
radiation-induced lung injury by inhibiting ROS and
epithelial-mesenchymal transition mediated by the TGF-β1/Smad
pathway. Pulm Pharmacol Ther. 87(102334)2024.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Sekine I, Sumi M, Ito Y, Nokihara H,
Yamamoto N, Kunitoh H, Ohe Y, Kodama T, Saijo N and Tamura T:
Retrospective analysis of steroid therapy for radiation-induced
lung injury in lung cancer patients. Radiother Oncol. 80:93–97.
2006.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Hashim AG, Brøndum RF, Nielsen MS, Laursen
KL, Vestergaard S, Heijkoop W and Szejniuk WM: Impact of
unsuccessful steroid tapering on survival in patients treated for
radiation pneumonitis following definitive radiation for non-small
cell lung cancer. Clin Lung Cancer. 26:e517–e526.e1.
2025.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Voruganti Maddali IS, Cunningham C, McLeod
L, Bahig H, Chaudhuri N, L M Chua K, Evison M, Faivre-Finn C,
Franks K, Harden S, et al: Optimal management of radiation
pneumonitis: Findings of an international Delphi consensus study.
Lung Cancer. 192(107822)2024.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Cravereau O, Bourbonne V, Vaugier L, Lucia
F, Tinier FL, Cadranel J, Duchemann B, Habert P, Martz N, Gehin W,
et al: AFSOS-SFRO guidelines on radiation-induced lung injury. Clin
Lung Cancer. 26:527–540. 2025.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Zhang J, Ge P, Liu J, Luo Y, Guo H, Zhang
G, Xu C and Chen H: Glucocorticoid treatment in acute respiratory
distress syndrome: An overview on mechanistic insights and clinical
benefit. Int J Mol Sci. 24(12138)2023.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Strandberg J, Louie A, Lee S, Hahn M,
Srinivasan P, George A, De La Cruz A, Zhang L, Hernandez Borrero L,
Huntington KE, et al: TRAIL agonists rescue mice from
radiation-induced lung, skin, or esophageal injury. J Clin Invest.
135(e173649)2025.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Chen G, Zhu J, Jian C, Chen X, Niu K, Yang
Q, Tang S, Qin S, Feng Y, Xie L, et al: Efficacy and safety of
Rh-endostatin in the treatment of radiation pneumonitis in
non-small cell lung cancer. Oncologist. 30(oyaf318)2025.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Liu B, Wang Y, Han G and Zhu M:
Tolerogenic dendritic cells in radiation-induced lung injury. Front
Immunol. 14(1323676)2024.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Tu J, Chen X, Li C, Liu C, Huang Y, Wang
X, Liang H and Yuan X: Nintedanib mitigates radiation-induced
pulmonary fibrosis by suppressing epithelial cell inflammatory
response and inhibiting fibroblast-to-myofibroblast transition. Int
J Biol Sci. 20:3353–3371. 2024.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Reed EB, Orbeta S, Miao BA, Sitikov A,
Chen B, Levitan I, Solway J, Mutlu GM, Fang Y, Mongin AA and Dulin
NO: Anoctamin-1 is induced by TGF-β and contributes to lung
myofibroblast differentiation. Am J Physiol Lung Cell Mol Physiol.
326:L111–L123. 2024.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Hua X, Hongbing R, Juan X, Jizan L and
Beibei Y: Dysregulation of TNF-induced protein 3 and
CCAAT/enhancer-binding protein β in alveolar macrophages:
Implications for systemic sclerosis-associated interstitial lung
disease. Int J Rheum Dis. 27(e15174)2024.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Liu W, Huang K, Yang XZ and Wang P:
Transcriptomic and network analysis identifies shared and unique
pathways and immune changes across fibrotic interstitial lung
diseases. Aging (Albany NY). 16:3200–3230. 2024.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Rimner A, Moore ZR, Lobaugh S, Geyer A,
Gelblum DY, Abdulnour RE, Shepherd AF, Shaverdian N, Wu AJ, Cuaron
J, et al: Randomized phase 2 placebo-controlled trial of nintedanib
for the treatment of radiation pneumonitis. Int J Radiat Oncol Biol
Phys. 116:1091–1099. 2023.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Ying H, Fang M, Hang QQ, Chen Y, Qian X
and Chen M: Pirfenidone modulates macrophage polarization and
ameliorates radiation-induced lung fibrosis by inhibiting the
TGF-β1/Smad3 pathway. J Cell Mol Med. 25:8662–8675. 2021.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Hou Z, Dong B, Yao Q, Chen H, Shao Q, Li
M, Wang J, Chen K, Zhu Z, Peng F, et al: Pirfenidone for grade 2
and grade 3 radiation-induced lung injury: A multicentre,
open-label, randomised, phase 2 trial. Lancet Oncol. 26:1552–1562.
2025.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Liu X, Lu F, Yang H, Liao G, Zhao L, Zou
D, He T, Hu Y, Wang L, Xia J, et al: Effectiveness and safety of
pirfenidone for radiation-induced lung injury in non-small cell
lung cancer: A retrospective pilot study. BMC Cancer.
25(1415)2025.PubMed/NCBI View Article : Google Scholar
|
|
42
|
De Ruysscher D, Granton PV, Lieuwes NG,
van Hoof S, Wollin L, Weynand B, Dingemans AM, Verhaegen F and
Dubois L: Nintedanib reduces radiation-induced microscopic lung
fibrosis but this cannot be monitored by CT imaging: A preclinical
study with a high precision image-guided irradiator. Radiother
Oncol. 124:482–487. 2017.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Zhang K, Ren L and Zhai Y: Effect and
mechanism of nintedanib on acute and chronic radiation-induced lung
injury in mice. PLoS One. 20(e0324339)2025.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Qin W, Liu B, Yi M, Li L, Tang Y, Wu B and
Yuan X: Antifibrotic agent pirfenidone protects against development
of radiation-induced pulmonary fibrosis in a murine model. Radiat
Res. 190:396–403. 2018.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Bai M, Liang G, Sun R, Dong Y, Geng C,
Wang B, Liu B and Sun L: Investigating the therapeutic role of
anlotinib in radiation-induced lung injury. Naunyn Schmiedebergs
Arch Pharmacol. 398:17633–17648. 2025.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Schaaf GW, Olson JD, Elgohari BA, Epperly
MW, Hou W, Wang H, Cline JM, Greenberger JS and Mukherjee A:
Radiation-induced lung injury (RILI) in non-human primates (NHPs)
induces cellular senescence and upregulation of tyrosine kinase
Fgr, which is detectable in bronchoalveolar lavage. Radiat Res.
204:354–368. 2025.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Soysouvanh F, Benadjaoud MA, Dos Santos M,
Mondini M, Lavigne J, Bertho A, Buard V, Tarlet G, Adnot S, Deutsch
E, et al: Stereotactic lung irradiation in mice promotes long-term
senescence and lung injury. Int J Radiat Oncol Biol Phys.
106:1017–1027. 2020.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Liu J, Ren X, Wang H, Yang D, Yan Y and Xu
Y: Dasatinib and quercetin mitigate radiation-induced lung injury
by eliminating senescent cells in a rat model. Front Pharmacol.
17(1748788)2026.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Maines LW, Keller SN, Smith RA, Green CL
and Smith CD: The sphingolipid-modulating drug opaganib protects
against radiation-induced lung inflammation and fibrosis: Potential
uses as a medical countermeasure and in cancer radiotherapy. Int J
Mol Sci. 25(2322)2024.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Zhang G, Sun N and Li X: Spleen tyrosine
kinase inhibition mitigates radiation-induced lung injury through
anti-inflammatory effects and downregulation of p38 MAPK and p53.
Front Oncol. 14(1406759)2024.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Lan Y, Moustafa M, Knoll M, Xu C, Furkel
J, Lazorchak A, Yeung TL, Hasheminasab SM, Jenkins MH, Meister S,
et al: Simultaneous targeting of TGF-β/PD-L1 synergizes with
radiotherapy by reprogramming the tumor microenvironment to
overcome immune evasion. Cancer Cell. 39:1388–1403.e10.
2021.PubMed/NCBI View Article : Google Scholar
|
|
52
|
Cho BC, Lee JS, Wu YL, Cicin I, Dols MC,
Ahn MJ, Cuppens K, Veillon R, Nadal E, Dias JM, et al: Bintrafusp
alfa versus pembrolizumab in patients with treatment-naive,
programmed death-ligand 1-high advanced NSCLC: A randomized,
open-label, phase 3 trial. J Thorac Oncol. 18:1731–1742.
2023.PubMed/NCBI View Article : Google Scholar
|
|
53
|
Qiu MZ, Bai Y, Wang J, Gu K, Yang M, He Y,
Yi C, Jin Y, Liu B, Wang F, et al: Addition of SHR-1701 to
first-line capecitabine and oxaliplatin (XELOX) plus bevacizumab
for unresectable metastatic colorectal cancer. Signal Transduct
Target Ther. 9(349)2024.PubMed/NCBI View Article : Google Scholar
|
|
54
|
Wang L, Liu C, Lu W, Xu L, Kuang L and Hua
D: ROS-sensitive Crocin-loaded chitosan microspheres for lung
targeting and attenuation of radiation-induced lung injury.
Carbohydr Polym. 307(120628)2023.PubMed/NCBI View Article : Google Scholar
|
|
55
|
Chen T, Zhuang B, Huang Y, Liu Y, Yuan B,
Wang W, Yuan T, Du L and Jin Y: Inhaled curcumin mesoporous
polydopamine nanoparticles against radiation pneumonitis. Acta
Pharm Sin B. 12:2522–2532. 2022.PubMed/NCBI View Article : Google Scholar
|
|
56
|
Li Y, Zhou B, Liu D, Nie G, Yang F, Chen
J, Cheng S, Kang Y, Liu B, Dong B and Liu M: Carbon monoxide gas
molecules: Therapeutic mechanisms in radiation-induced lung injury.
J Colloid Interface Sci. 688:250–263. 2025.PubMed/NCBI View Article : Google Scholar
|
|
57
|
Chen Y, Liu X and Tong Z: Mesenchymal stem
cells in radiation-induced pulmonary fibrosis: Future prospects.
Cells. 12(6)2022.PubMed/NCBI View Article : Google Scholar
|
|
58
|
Zhai R, Tai F, Ding K, Tan X, Li H, Cao Z,
Ge C, Zheng X and Fu H: Comparative analysis of the therapeutic
effects of MSCs from umbilical cord, bone marrow, and adipose
tissue and investigating the impact of oxidized RNA on
radiation-induced lung injury. Stem Cells Int.
2024(7419270)2024.PubMed/NCBI View Article : Google Scholar
|
|
59
|
Zhou H, Zhang Y, Pei P, Shen W, Yi X and
Yang K: Liposome-anchored mesenchymal stem cells for radiation
pneumonia/fibrosis treatment. Biomaterials.
300(122202)2023.PubMed/NCBI View Article : Google Scholar
|
|
60
|
Wang LL, Ouyang MY, Yang ZE, Xing SN, Zhao
S and Yu HY: Mesenchymal stem cells-derived exosomes alleviate
radiation induced pulmonary fibrosis by inhibiting the protein
kinase B/nuclear factor kappa B pathway. World J Stem Cells.
17(106488)2025.PubMed/NCBI View Article : Google Scholar
|
|
61
|
Dasgupta Q, Jiang A, Wen AM, Mannix RJ,
Man Y, Hall S, Javorsky E and Ingber DE: A human lung
alveolus-on-a-chip model of acute radiation-induced lung injury.
Nat Commun. 14(6506)2023.PubMed/NCBI View Article : Google Scholar
|
|
62
|
Yamaguchi K, Egashira R, Nakazono T,
Yoshinaga Y, Baba K, Kataoka M, Yabuuchi H, Aoki T and Togao O: CT
findings of lung injury during breast cancer treatment. Breast
Cancer. 33:50–61. 2026.PubMed/NCBI View Article : Google Scholar
|
|
63
|
Jo NC, Shroff GS, Ahuja J, Agrawal R,
Price MC and Wu CC: Radiation recall pneumonitis: Imaging
appearance and differential considerations. Korean J Radiol.
25:843–850. 2024.PubMed/NCBI View Article : Google Scholar
|
|
64
|
Liu Y, Yang X, Wang Y, Zhou L and Xue J:
Real-world analysis of the incidence and risk factors of
pneumonitis in non-small cell lung cancer patients treated with
combined thoracic radiotherapy and immunotherapy. Oncologie.
26:1003–1017. 2024.
|
|
65
|
Qin Y, Mo Y, Li P, Liang X, Yu J and Chen
D: Early immune checkpoint inhibitor administration increases the
risk of radiation-induced pneumonitis in patients with stage III
unresectable NSCLC undergoing chemoradiotherapy. Cancers (Basel).
17(1711)2025.PubMed/NCBI View Article : Google Scholar
|
|
66
|
Yerolatsite M, Torounidou N, Amylidi AL,
Rapti IC, Zarkavelis G, Kampletsas E and Voulgari PV: A systematic
review of pneumonitis following treatment with immune checkpoint
inhibitors and radiotherapy. Biomedicines. 13(946)2025.PubMed/NCBI View Article : Google Scholar
|
|
67
|
Schuh D and Kemmer C: Radiation
pneumonitis. Morphology and pathogenesis. Zentralbl Allg Pathol.
134:611–626. 1988.PubMed/NCBI(In German).
|
|
68
|
Mei T, Yang X, Yu Y, Tian X, Deng Q, Xu Y,
Zhou L, Zhou X, Liu Y, Zou B, et al: Secondary infections after
diagnosis of severe radiation pneumonitis (SRP) among patients with
non-small cell lung cancer: Pathogen distributions, choice of
empirical antibiotics, and the value of empirical antifungal
treatment. Int J Radiat Oncol Biol Phys. 112:179–187.
2022.PubMed/NCBI View Article : Google Scholar
|
